Welcome to LookChem.com Sign In|Join Free

CAS

  • or

210539-03-0

210539-03-0

Post Buying Request

210539-03-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

210539-03-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 210539-03-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,0,5,3 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 210539-03:
(8*2)+(7*1)+(6*0)+(5*5)+(4*3)+(3*9)+(2*0)+(1*3)=90
90 % 10 = 0
So 210539-03-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H18N2O/c18-15-7-6-13-11-17(9-8-14(13)16-15)10-12-4-2-1-3-5-12/h1-5H,6-11H2,(H,16,18)

210539-03-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-benzyl-1,3,4,5,7,8-hexahydro-1,6-naphthyridin-2-one

1.2 Other means of identification

Product number -
Other names 6-benzyl-3,4,5,6,7,8-hexahydro-1,6-naphthyridin-2(1H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:210539-03-0 SDS

210539-03-0Relevant articles and documents

ANTI-PULMONARY TUBERCULOSIS NITROIMIDAZOLE DERIVATIVE

-

Paragraph 0108; 0111; 0112, (2017/12/31)

Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.

Substituted tetrahydroisoquinoline compound and application

-

Paragraph 0181; 0184; 0185, (2017/07/23)

The invention discloses a substituted tetrahydroisoquinoline compound and application. The compound has a structure as shown in a general formula I in the specification; and in the general formula I, substituents are defined in the specification. The comp

Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof

-

Page/Page column 8, (2008/12/06)

Tetrahydroquinolinone and tetrahydronaphthyridone cannabinoid receptor ligand compounds and stereoisomers, mixtures of stereoisomers, prodrugs, pharmaceutically acceptable salts, hydrates, solvates, acid salt hydrates, and isomorphic crystalline forms the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 210539-03-0